Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(1):87–94. doi: 10.1111/j.1750-3639.2002.tb00425.x

Insulin‐like Growth Factor Binding Protein 2: Gene Expression Microarrays and the Hypothesis‐generation Paradigm

Wei Zhang 1,✉, Hua Wang 1, Sonya W Song 1, Gregory N Fuller 1
PMCID: PMC8095777  PMID: 11770904

Abstract

A major goal of modern medicine is to identify key genes and their products that are altered in the diseased state and to elucidate the molecular mechanisms underlying disease development, progression, and resistance to therapy. This is a daunting task given the exceptionally high complexity of the human genome. The paradigm for research has historically been hypothesis‐driven despite the fact that the hypotheses under scrutiny often rest on tenuous subjective grounds or are derived from and dependent on chance observation. The imminent deciphering of the complete human genome, coupled with recent advances in high‐throughput bioanalytical technology, has made possible a new paradigm in which data‐based hypothesis‐generation is the initial step in the investigative process, followed by hypothesis‐testing. Genomics technologies are the primary source of the new hypothesis‐generating capabilities that are now empowering biomedical researchers. The synergistic interaction between contemporary genomics technologies and the hypothesis‐generation paradigm is well‐illustrated by the discovery and subsequent ongoing study of the role of insulin‐like growth factor binding protein 2 (IGFBP2) in human glioma biology. Using gene expression microarray technology, the IGFBP2 gene was recently found to be highly and differentially overexpressed in the most advanced grade of human glioma, glioblastoma. Based on this discovery, subsequent functional studies were initiated that suggest that IGFBP2 overexpression may contribute to the invasive nature of glioblastoma, and that IGFBP2 may exert its function via a newly identified novel binding protein. The IGFBP2 story is but one example of the power and potential of the new molecular methodologies that are transforming modern diagnostic and investigative neuropathology.

Full Text

The Full Text of this article is available as a PDF (39.6 KB).

References

  • 1. Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AM, DiDonato S, Finocchiaro G (1996) Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor‐suppressor genes in a 17‐cM interval on chromosome 10q . Am J Hum Genet 58:1260–1267. [PMC free article] [PubMed] [Google Scholar]
  • 2. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245. [PubMed] [Google Scholar]
  • 3. Allan GJ, Flint DJ, Darling SM, Geh J, Patel K (2000) Altered expression of insulin‐like growth factor‐1 and insulin like growth factor binding proteins‐2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity. Anat Embryol (Berl) 202:1–11. [DOI] [PubMed] [Google Scholar]
  • 4. Babajko S, Grellier P, De Galle B, Menouny M, Binoux M (2001) IGFBPs are involved in xenograft development in nude mice. Med Pediatr Oncol 36:154–156. [DOI] [PubMed] [Google Scholar]
  • 5. Baker NL, Carlo Russo V, Bernard O, D'Ercole AJ, Werther GA (1999) Interactions between bcl‐2 and the IGF system control apoptosis in the developing mouse brain. Brain Res Dev Brain Res 118:109–118. [DOI] [PubMed] [Google Scholar]
  • 6. Baltimore D (2001) Our genome unveiled. Nature 409:814–816. [DOI] [PubMed] [Google Scholar]
  • 7. Banks RE, Craven, R. , Harnden, P. , and Selby, P. J. (2000) The use of laser capture microdissection to obtain distinct populations of cells for proteomic analysis. JMM 78:B28. [Google Scholar]
  • 8. Blum WF, Horn N, Kratzsch J, Jorgensen JO, Juul A, Teale D, Mohnike K, Ranke MB (1993) Clinical studies of IGFBP‐2 by radioimmunoassay. Growth Regul 3:100–104. [PubMed] [Google Scholar]
  • 9. Bogler O, Huang HJ, Kleihues P, Cavenee WK (1995) The p53 gene and its role in human brain tumors. Glia 15:308–327. [DOI] [PubMed] [Google Scholar]
  • 10. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez‐Bigas MA, Fodde R, Ranzani GN et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257. [PubMed] [Google Scholar]
  • 11. Bowtell DD (1999) Options available—from start to finish‐for obtaining expression data by microarray. Nat Genet 21:25–32. [DOI] [PubMed] [Google Scholar]
  • 12. Cairncross JG (1998) Cognition in survivors of high‐grade glioma. J Clin Oncol 16:3210–3211. [DOI] [PubMed] [Google Scholar]
  • 13. Cerro JA, Grewal A, Wood TL, Pintar JE (1993) Tissue‐specific expression of the insulin‐like growth factor binding protein (IGFBP) mRNAs in mouse and rat development. Regul Pept 48:189–198. [DOI] [PubMed] [Google Scholar]
  • 14. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Jr. , Fontana JA (1994) Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐I (IGF‐I)‐mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell line. J Cell Physiol 158:69–78. [DOI] [PubMed] [Google Scholar]
  • 15. Clemmons DR (1997) Insulin‐like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45–62. [DOI] [PubMed] [Google Scholar]
  • 16. Collett‐Solberg PF, Cohen P (1996) The role of the insulin‐like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25:591–614. [DOI] [PubMed] [Google Scholar]
  • 17. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14:457–460. [DOI] [PubMed] [Google Scholar]
  • 18. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ et al (1999) The DNA sequence of human chromosome 22. Nature 402:489–495. [DOI] [PubMed] [Google Scholar]
  • 19. Elmlinger MW, Deininger MH, Schuett BS, Meyermann R, Duffner F, Grote EH, Ranke MB (2001) In vivo expression of insulin‐like growth factor‐binding protein‐2 in human gliomas increases with the tumor grade. Endocrinology 142:1652–1658. [DOI] [PubMed] [Google Scholar]
  • 20. Emmert‐Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA (1996) Laser capture microdissection. Science 274:998–1001. [DOI] [PubMed] [Google Scholar]
  • 21. Ferry J (2000) “Working draft” of human genome available by June. Lancet 355:1337. [DOI] [PubMed] [Google Scholar]
  • 22. Feyen JH, Evans DB, Binkert C, Heinrich GF, Geisse S, Kocher HP (1991) Recombinant human [Cys281]insulin‐like growth factor‐binding protein 2 inhibits both basal and insulin‐like growth factor I‐stimulated proliferation and collagen synthesis in fetal rat calvariae. J Biol Chem 266:19469–19474. [PubMed] [Google Scholar]
  • 23. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU (1992) Amplification and/or overexpression of platelet‐derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550–4553. [PubMed] [Google Scholar]
  • 24. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS (1997) Elevated serum insulin‐like growth factor‐binding protein 2 (IGFBP‐2) and decreased IGFBP‐3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor‐associated trypsin inhibitor. J Clin Endocrinol Metab 82:2308–2313. [DOI] [PubMed] [Google Scholar]
  • 25. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS et al (1998) Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol 153:1063–1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W (1999) Reactivation of insulin‐like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 59:4228–4232. [PubMed] [Google Scholar]
  • 27. Gehrmann J, Yao DL, Bonetti B, Bondy CA, Brenner M, Zhou J, Kreutzberg GW, Webster HD (1994) Expression of insulin‐like growth factor‐I and related peptides during motoneuron regeneration. Exp Neurol 128:202–210. [DOI] [PubMed] [Google Scholar]
  • 28. Gleeson LM, Chakraborty C, McKinnon T, Lala PK (2001) Insulin‐like growth factor‐binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen‐activated protein Kinase pathway. J Clin Endocrinol Metab 86:2484–2493. [DOI] [PubMed] [Google Scholar]
  • 29. Gockerman A, Prevette T, Jones JI, Clemmons DR (1995) Insulin‐like growth factor (IGF)‐binding proteins inhibit the smooth muscle cell migration responses to IGF‐I and IGF‐II. Endocrinology 136:4168–4173. [DOI] [PubMed] [Google Scholar]
  • 30. Green BN, Jones SB, Streck RD, Wood TL, Rotwein P, Pintar JE (1994) Distinct expression patterns of insulin‐like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 134:954–962. [DOI] [PubMed] [Google Scholar]
  • 31. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70. [DOI] [PubMed] [Google Scholar]
  • 32. Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK et al (2000) The DNA sequence of human chromosome 21. Nature 405:311–319. [DOI] [PubMed] [Google Scholar]
  • 33. He J, Olson JJ, James CD (1995) Lack of p16INK4 or retinoblastoma protein (pRb), or amplification‐associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55:4833–4836. [PubMed] [Google Scholar]
  • 34. Hoeflich A, Fettscher O, Lahm H, Blum WF, Kolb HJ, Engelhardt D, Wolf E, Weber MM (2000) Overexpression of insulin‐like growth factor‐binding protein‐2 results in increased tumorigenic potential in Y‐1 adrenocortical tumor cells. Cancer Res 60:834–838. [PubMed] [Google Scholar]
  • 35. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E (1999) Overexpression of insulin‐like growth factor‐binding protein‐2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488–5496. [DOI] [PubMed] [Google Scholar]
  • 36. Hogenesch JB, Ching KA, Batalov S, Su AI, Walker JR, Zhou Y, Kay SA, Schultz PG, Cooke MP (2001) A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell 106:413–415. [DOI] [PubMed] [Google Scholar]
  • 37. Hwa V, Oh Y, Rosenfeld RG (1999) Insulin‐like growth factor binding proteins: a proposed superfamily. Acta Paediatr Suppl 88:37–45. [DOI] [PubMed] [Google Scholar]
  • 38. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818–821. [DOI] [PubMed] [Google Scholar]
  • 39. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A (1993) Serum insulin‐like growth factor‐binding protein‐2 (IGFBP‐2) is increased and IGFBP‐3 is decreased in patients with prostate cancer: correlation with serum prostate‐specific antigen. J Clin Endocrinol Metab 77:229–233. [DOI] [PubMed] [Google Scholar]
  • 40. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG (1996) Insulin‐like growth factor‐binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619–637. [DOI] [PubMed] [Google Scholar]
  • 41. Klempt M, Klempt ND, Gluckman PD (1993) Hypoxia and hypoxia/ischemia affect the expression of insulin‐like growth factor binding protein 2 in the developing rat brain. Brain Res Mol Brain Res 17:347–350. [DOI] [PubMed] [Google Scholar]
  • 42. Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30:441–464. [DOI] [PubMed] [Google Scholar]
  • 43. Lee WH, Michels KM, Bondy CA (1993) Localization of insulin‐like growth factor binding protein‐2 messenger RNA during postnatal brain development: correlation with insulin‐like growth factors I and II. Neuroscience 53:251–265. [DOI] [PubMed] [Google Scholar]
  • 44. Lenoir D, Honegger P (1983) Insulin‐like growth factor I (IGF I) stimulates DNA synthesis in fetal rat brain cell cultures. Brain Res 283:205–213. [DOI] [PubMed] [Google Scholar]
  • 45. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R. et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947. [DOI] [PubMed] [Google Scholar]
  • 46. Lim R, Miller JF, Hicklin DJ, Holm AC, Ginsberg BH (1985) Mitogenic activity of glia maturation factor. Interaction with insulin and insulin‐like growth factor‐II. Exp Cell Res 159:335–343. [DOI] [PubMed] [Google Scholar]
  • 47. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ (1999) High density synthetic oligonucleotide arrays. Nat Genet 21:20–24. [DOI] [PubMed] [Google Scholar]
  • 48. Lleonart ME, Martin‐Duque P, Sanchez‐Prieto R, Moreno A, Ramony Cajal S (2000) Tumor heterogeneity: morphological, molecular and clinical implications. Histol Histopathol 15:881–898. [DOI] [PubMed] [Google Scholar]
  • 49. Lockhart DJ, Winzeler EA (2000) Genomics, gene expression and DNAarrays. Nature 405:827–836. [DOI] [PubMed] [Google Scholar]
  • 50. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW (1986) Insulin‐like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A 83:822–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Menouny M, Binoux M, Babajko S (1998) IGFBP‐2 expression in a human cell line is associated with increased IGFBP‐3 proteolysis, decreased IGFBP‐1 expression and increased tumorigenicity. Int J Cancer 77:874–879. [DOI] [PubMed] [Google Scholar]
  • 52. Morford LA, Boghaert ER, Brooks WH, Roszman TL (1997) Insulin‐like growth factors (IGF) enhance three‐dimensional (3D) growth of human glioblastomas. Cancer Lett 115:81–90. [DOI] [PubMed] [Google Scholar]
  • 53. Muller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG (1994) Insulin‐like growth factor‐binding protein‐2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 79:428–434. [DOI] [PubMed] [Google Scholar]
  • 54. Paleologos NA, Cairncross JG (1999) Treatment of oligo‐dendroglioma: an update. Neuro-oncol 1:61–68. [PMC free article] [PubMed] [Google Scholar]
  • 55. Park JH, McCusker RH, Vanderhoof JA, Mohammadpour H, Harty RF, MacDonald RG (1992) Secretion of insulin‐like growth factor II (IGF‐II) and IGF‐binding protein‐2 by intestinal epithelial (IEC‐6) cells: implications for autocrine growth regulation. Endocrinology 131:1359–1368. [DOI] [PubMed] [Google Scholar]
  • 56. Penn SG, Rank DR, Hanzel DK, Barker DL (2000) Mining the human genome using microarrays of open reading frames. Nat Genet 26:315–318. [DOI] [PubMed] [Google Scholar]
  • 57. Phillips J, Eberwine JH (1996) Antisense RNA amplifica‐tion: A linear amplification method for analyzing the mRNA population from single living cells. Methods 10:283–288. [DOI] [PubMed] [Google Scholar]
  • 58. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y. et al (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207–211. [DOI] [PubMed] [Google Scholar]
  • 59. Pintar JE, Cerro JA, Wood TL (1996) Genetic approaches to the function of insulin‐like growth factor‐binding proteins during rodent development. Horm Res 45:172–177. [DOI] [PubMed] [Google Scholar]
  • 60. Pintar JE, Schuller A, Cerro JA, Czick M, Grewal A, Green B (1995) Genetic ablation of IGFBP‐2 suggests functional redundancy in the IGFBP family. Prog Growth Factor Res 6:437–445. [DOI] [PubMed] [Google Scholar]
  • 61. Rashid A, Zahurak M, Goodman SN, Hamilton SR (1999) Genetic epidemiology of mutated K‐ras proto‐oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut 44:826–833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Rechler MM, Nissley SP (1985) The nature and regulation of the receptors for insulin‐like growth factors. Annu Rev Physiol 47:425–442. [DOI] [PubMed] [Google Scholar]
  • 63. Reeve JG, Morgan J, Schwander J, Bleehen NM (1993) Role for membrane and secreted insulin‐like growth factor‐binding protein‐2 in the regulation of insulin‐like growth factor action in lung tumors. Cancer Res 53:4680–4685. [PubMed] [Google Scholar]
  • 64. Reifenberger J, Reifenberger G, Liu L, James CD, Wech‐sler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175–1190. [PMC free article] [PubMed] [Google Scholar]
  • 65. Rew DA (1998) The importance of heterogeneity in tumor pathology. Adv Anat Pathol 5:156–163. [DOI] [PubMed] [Google Scholar]
  • 66. Rowley JD (1998) The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32:495–519. [DOI] [PubMed] [Google Scholar]
  • 67. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J (2000) Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 60:6617–6622. [PubMed] [Google Scholar]
  • 68. Sandberg Nordqvist AC, von Holst H, Holmin S, Sara VR, Bellander BM, Schalling M (1996) Increase of insulin‐like growth factor (IGF)‐1, IGF binding protein‐2 and ‐4 mRNAs following cerebral contusion. Brain Res Mol Brain Res 38:285–293. [DOI] [PubMed] [Google Scholar]
  • 69. Shemer J, Raizada MK, Masters BA, Ota A, LeRoith D (1987) Insulin‐like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture. J Biol Chem 262:7693–7699. [PubMed] [Google Scholar]
  • 70. Slootweg MC, Ohlsson C, Salles JP, De Vries CP, Nete‐lenbos JC (1995) Insulin‐like growth factor binding proteins‐2 and ‐3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136:4210–4217. [DOI] [PubMed] [Google Scholar]
  • 71. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B. et al (2000) Genes expressed in human tumor endothelium. Science 289:1197–1202. [DOI] [PubMed] [Google Scholar]
  • 72. Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 12:255–261. [DOI] [PubMed] [Google Scholar]
  • 73. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T. et al (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362. [DOI] [PubMed] [Google Scholar]
  • 74. Sullivan KA, Feldman EL (1994) Immunohistochemical localization of insulin‐like growth factor‐II (IGF‐II) and IGF‐binding protein‐2 during development in the rat brain. Endocrinology 135:540–547. [DOI] [PubMed] [Google Scholar]
  • 75. Toyota M, Shen L, Ohe‐Toyota M, Hamilton SR, Sinicrope FA, Issa JP (2000) Aberrant methylation of the Cyclooxy‐genase 2 CpG island in colorectal tumors. Cancer Res 60:4044–4048. [PubMed] [Google Scholar]
  • 76. Velculescu VE, Vogelstein B, Kinzler KW (2000) Analysing uncharted transcriptomes with SAGE. Trends Genet 16:423–425. [DOI] [PubMed] [Google Scholar]
  • 77. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW (1995) Serial analysis of gene expression. Science 270:484–487. [DOI] [PubMed] [Google Scholar]
  • 78. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM (2000) High‐fidelity mRNA amplification for gene profiling. Nat Biotechnol 18:457–459. [DOI] [PubMed] [Google Scholar]
  • 79. Werther GA, Russo V, Baker N, Butler G (1998) The role of the insulin‐like growth factor system in the developing brain. Horm Res 49:37–40. [DOI] [PubMed] [Google Scholar]
  • 80. Wood TL, Rogler L, Streck RD, Cerro J, Green B, Grew‐al A, Pintar JE (1993) Targeted disruption of IGFBP‐2 gene. Growth Regul 3:5–8. [PubMed] [Google Scholar]
  • 81. Wood TL, Streck RD, Pintar JE (1992) Expression of the IGFBP‐2 gene in post‐implantation rat embryos. Development 114:59–66. [DOI] [PubMed] [Google Scholar]
  • 82. Zapf J, Schoenle E, Froesch ER (1978) Insulin‐like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin‐like activity of human serum. Eur J Biochem 87:285–296. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES